Halina Antosz

Summary

Affiliation: Medical University
Country: Poland

Publications

  1. ncbi [Negative regulation of Toll-like receptor signalling]
    Halina Antosz
    Zakład Genetyki Klinicznej, Uniwersytet Medyczny, 20 080 Lublin, Poland
    Postepy Hig Med Dosw (Online) 67:339-50. 2013
  2. doi Aberrant TIRAP and MyD88 expression in B-cell chronic lymphocytic leukemia
    Halina Antosz
    Department of Clinical Genetics, Medical University of Lublin, Lublin, Poland
    Blood Cells Mol Dis 51:48-55. 2013
  3. doi TLR2 may influence the behavior of the malignant clone in B-CLL
    Halina Antosz
    Department of Clinical Genetics, Medical University of Lublin, Lublin, Poland
    Blood Cells Mol Dis 49:32-40. 2012
  4. doi Different expression of CD180, CD284 and CD14 receptors on the CD19+ subpopulation of normal and B-CLL lymphocytes
    Halina Antosz
    Department of Clinical Genetics, Medical University in Lublin, Poland
    Folia Histochem Cytobiol 47:593-8. 2009
  5. doi Alterations in TP53, cyclin D2, c-Myc, p21WAF1/CIP1 and p27KIP1 expression associated with progression in B-CLL
    Antosz Halina
    Department of Clinical Genetics, Medical University of Lublin, Lublin, Poland
    Folia Histochem Cytobiol 48:534-41. 2010

Collaborators

  • Antosz Halina
  • Sajewicz Joanna
  • Paterski Artur
  • Marzec Kotarska Barbara
  • Dmoszyńska Anna

Detail Information

Publications5

  1. ncbi [Negative regulation of Toll-like receptor signalling]
    Halina Antosz
    Zakład Genetyki Klinicznej, Uniwersytet Medyczny, 20 080 Lublin, Poland
    Postepy Hig Med Dosw (Online) 67:339-50. 2013
    ..These molecules maintain the balance between activation and inhibition and ensure balancing of the beneficial and adverse effects of antigen recognition...
  2. doi Aberrant TIRAP and MyD88 expression in B-cell chronic lymphocytic leukemia
    Halina Antosz
    Department of Clinical Genetics, Medical University of Lublin, Lublin, Poland
    Blood Cells Mol Dis 51:48-55. 2013
    ..The results of our study suggest that there may exist a, yet unknown, defect of TIRAP and MyD88 proteins in B-CLL lymphocytes...
  3. doi TLR2 may influence the behavior of the malignant clone in B-CLL
    Halina Antosz
    Department of Clinical Genetics, Medical University of Lublin, Lublin, Poland
    Blood Cells Mol Dis 49:32-40. 2012
    ..TLR2 may influence the behaviour of the malignant clone in B-CLL...
  4. doi Different expression of CD180, CD284 and CD14 receptors on the CD19+ subpopulation of normal and B-CLL lymphocytes
    Halina Antosz
    Department of Clinical Genetics, Medical University in Lublin, Poland
    Folia Histochem Cytobiol 47:593-8. 2009
    ..Variations observed in expression of both normal and leukemic receptors may be due to their different sensitivity to antigenic stimulation...
  5. doi Alterations in TP53, cyclin D2, c-Myc, p21WAF1/CIP1 and p27KIP1 expression associated with progression in B-CLL
    Antosz Halina
    Department of Clinical Genetics, Medical University of Lublin, Lublin, Poland
    Folia Histochem Cytobiol 48:534-41. 2010
    ..Moreover, high expression levels of TP53 and c-Myc genes were found to be closely associated with more aggressive forms of the disease requiring earlier therapy...